Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 1
1966 3
1968 8
1977 1
1978 6
1979 3
1980 1
1982 1
1983 2
1984 5
1985 3
1986 2
1987 3
1988 3
1989 1
1990 3
1991 2
1992 7
1993 3
1994 2
1995 4
1996 5
1997 3
1998 2
1999 6
2000 6
2001 4
2002 12
2003 7
2004 6
2005 7
2006 7
2007 4
2008 9
2009 3
2010 10
2011 10
2012 12
2013 21
2014 10
2015 19
2016 30
2017 18
2018 27
2019 31
2020 38
2021 29
2022 28
2023 29
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

447 results

Results by year

Filters applied: . Clear all
Page 1
Italian Guidelines for the Management of Prolactinomas.
Cozzi R, Simona Auriemma R, De Menis E, Esposito F, Ferrante E, Iatì G, Mazzatenta D, Poggi M, Rudà R, Tortora F, Cruciani F, Mitrova Z, Saulle R, Vecchi S, Basile M, Cappabianca P, Paoletta A, Papini E, Persichetti A, Samperi I, Scoppola A, Bozzao A, Caputo M, Doglietto F, Ferraù F, Lania AG, Laureti S, Lello S, Locatelli D, Maffei P, Minniti G, Peri A, Ruini C, Settanni F, Silvani A, Veronese N, Grimaldi F, Attanasio R. Cozzi R, et al. Among authors: basile m. Endocr Metab Immune Disord Drug Targets. 2023;23(12):1459-1479. doi: 10.2174/1871530323666230511104045. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37171003 Free PMC article.
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project).
Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker SD, Bejuit R, Bordes P, Cherubini A, Cruz-Jentoft AJ, Di Bari M, Friede T, Gorostiaga Ayestarán C, Goyeau H, Jónsson PV, Kashiwa M, Lattanzio F, Maggio M, Mariotti L, Miller RR, Rodriguez-Mañas L, Roller-Wirnsberger R, Rýznarová I, Scholpp J, Schols AMWJ, Sieber CC, Sinclair AJ, Skalska A, Strandberg T, Tchalla A, Topinková E, Tosato M, Vellas B, von Haehling S, Pahor M, Roubenoff R, Marzetti E; SPRINTT consortium. Bernabei R, et al. BMJ. 2022 May 11;377:e068788. doi: 10.1136/bmj-2021-068788. BMJ. 2022. PMID: 35545258 Free PMC article. Clinical Trial.
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective.
Salvioli S, Basile MS, Bencivenga L, Carrino S, Conte M, Damanti S, De Lorenzo R, Fiorenzato E, Gialluisi A, Ingannato A, Antonini A, Baldini N, Capri M, Cenci S, Iacoviello L, Nacmias B, Olivieri F, Rengo G, Querini PR, Lattanzio F. Salvioli S, et al. Among authors: basile ms. Ageing Res Rev. 2023 Nov;91:102044. doi: 10.1016/j.arr.2023.102044. Epub 2023 Aug 28. Ageing Res Rev. 2023. PMID: 37647997 Free article. Review.
Budget impact analysis sull’introduzione del dispositivo di telemonitoraggio Turbo+ nella gestione dei pazienti asmatici in Italia.
Rumi F, Basile M, Cicchetti A, Contiguglia R, Pentassuglia A, Oliva A, Senna G, Bonavia M, Scarpelli F, Benvenuto M. Rumi F, et al. Among authors: basile m. Glob Reg Health Technol Assess. 2022 Apr 19;9:58-67. doi: 10.33393/grhta.2022.2290. eCollection 2022 Jan-Dec. Glob Reg Health Technol Assess. 2022. PMID: 36628312 Free PMC article. Italian.
Out of Touch.
Mangione S, Basile M, Post SG. Mangione S, et al. Among authors: basile m. JAMA. 2024 Mar 5;331(9):729-730. doi: 10.1001/jama.2024.0888. JAMA. 2024. PMID: 38334986
447 results